Honey Bee Venom has various biological activities such as inhibitory effect on several types of cancer. Cisplatin is an old and potent drug to treat the most of cancer. Our aims in this study were determination of the anti-mutagenic and cytotoxic effects of HBV on mammary carcinoma, lonely and in combination with cisplatin. In this study 4T1 cell line were cultured and incubated at 37  C in humidified CO2-incubator. The cell viabilities were examined by MTT assay.
Introduction
Breast cancer is originated from the breast tissue and uncontrolled growth of cells from the inner lining of milk ducts or lobules 1 . Breast cancer is the most common diagnosed cancer and the main cause of cancer death among females worldwide 2 .
Several studies have shown that breast carcinoma is occurred mostly in undifferentiated structures of breast and these structures are the origin site of ductal carcinoma. Approximately 1-2 years after onset of the first menstrual period, lobule formation is started. There is a gradual process for mammary gland which it needs several years. Parous women particularly women who have full term pregnancy experience at young age, have full lobular differentiation in breast structure 3 . The most risk factors for breast cancer have been estimated and studied included diet, oral contraception, postmenopausal substituent treatment with estrogen, breast irradiation, and environment 4 .
The 4T1 mouse mammary tumor cell line is a model of breast cancer which able to metastasize to site affected in human breast cancer. In 1983, Fred Miller and coworkers isolated the 4T1 cell line from BALB/c mammary tumor. This cell line has capacity to metastasize to bone and several organs affected in breast cancer consist of lungs, liver, brain. Hence in the recent years, usage of this cell line has increased 5 .
The molecular studies of mammary tumors indicated that the amplification of oncogenic genes such as erb-B1, erb-B2, c-myc , int-2 are common 6 . About 5-10% of all breast cancer cases are hereditary breast cancer. BRCA1, tumor suppressor gene, is mutated in the most hereditary breast and ovarian cancer 7 .
Recently treatment of cancer is a global concern. The various types of cancer treatment ways such as surgery, anticancer drug (chemotherapy), irradiation, hormone therapy, nutritional supplementation are used. Chemotherapy is a systematic therapy in which all of body cells are exposed to chemotropic agents 8 .
Usage of metals as medicine traces back to 5000 years ago. The studies on inorganic chemist develop modern medicine with metal components to treat disease such as cancer Cisplatin [cis-dichlorodiammineplatinum(II)] is a first stage of chemotherapy for most cancer including testicular, ovarian, cervical, small lung-cell and also breast cancer 9 .
Nevertheless cytotoxic effect of cisplatin depends on dosage, and its high dosage has improvement effects on cancerous cells. However, usage of cisplatin is limited because it has several side effects specially nephrotoxicity and neurotoxicity effects 10 .
Honey bee venom (HBV) is an active product which is produced by the venom glands associated with the sting apparatus of honey bee workers and their queen.
The history of apitherapy traces back 3000 to 5000 years ago 11 . HBV is a very complex mixture of active enzymes, peptides and amines. Its most important components are Melittin and phospholipase A 2, Adolapin and mast cell degranulating peptide. The several in-vitro and in-vivo studies revealed that HBV has antiinflammatory, cytotoxic and antibacterial effects and also it can cause severe allergic reaction 12 . HBV as an old medicine has been used to treat arthritis, rheumatism, back pain, cancerous tumors, and skin diseases 13 .
Our aims in this study were attended to investigate the cytotoxic effect of honeybee venom on 4T1 cell line, lonely and in combination with cisplatin, and also analysis of anti-mutagenic activity and anti-cancerous effects of bee venom by Ames test.
Materials and methods:
Cell culture Mouse mammary carcinoma 4T1 cell line was purchased from Pasteur Institute of Iran cell bank. Cells were cultured in RPMI-1640 (Gibco-Invitrogene) with 10% fetal bovine serum (FBS), (Gibco-Invitrogene) and antibiotics (100U/ml penicillin and 100mg/ml streptomycin) at 37  C in a 5% CO 2 and 95% O 2 humidified incubator.
Exhausted medium was changed every 24h.
HBV preparation
Iranian honeybee venom was collected from Apis mellifera by means of an electric shocker apparatus composed of a shocker and collector unit. The shocker unit produces a light electric shock once every few seconds. Honeybees were stimulated with light electric shock and sting in beehives. The collector unit is a network of wires with small gaps and a glass plane between them. Every 25 minutes, the shocker unit turned off and the dried bee venom material on collector panel was collected by scarping.
HBV was stored as powder at -20 °C and dark condition. The main stock solution of HBV was prepared with 1mg of HBV and 1 ml phosphate buffer saline (PBS). In order to obtain a homogen and sterile solution, finally this solution was passed filter with 0.2 µm micropore. For every assay this solution was prepared freshly. For Ames assay concentration of the main stock solution was 10 mg/ml (HBV+PBS) and interested concentrations were obtained by dilution the main stock.
Cisplatin preparation
Cisplatin was purchased from Sobhan Oncology Company of Iran. Its concentration was 50mg/ml and it was stored at 4°C and dark situation. Interested concentrations were obtained by dilution the main stock.
MTT assay
The MTT assay is one the basis reduction of yellow MTT-dimethylthiazol diphenyl tetrazolium bromide-(tetrazole) to purple Formazan crystal by mitochondrial dehydrogenase in living cells. Adherent 4T1 cells were trypsinized by trypsin-EDTA 0.25% (Gibco-Invitrogene) then seeded in 24-well plate and cultured overnight in order to full adherence of cells to plate. The cells were treated with different concentrations of honeybee venom 0 as control , 2, 4, 6, 8, 10 g/ml, and cisplatin ,0 as control, 5,10,15,20,25,30 μg/ml, and also cisplatin and HBV together,0 as control, 2+10, 4+10, 6+10 ,8+10, 10+10 g/ml, for 24h. Cell viability was measured using MTT assay (Sigma-America). MTT solution was prepared (5mg MTT powder in 1ml PBS) and then it was filtered. After 24h incubation of treated cells, 50l MTT solution was added to each well, and the plate was incubated in 37C for 4 hours and dark situation. Subsequently, the supernatant liquid was removed and 1ml DMSO, dimethylsulfoxide, (Merck, Germany) was added to each well, and plate was kept at room temperature for 15 minutes. Finally, the absorbance was measured at 570nm wavelength by a spectrophotometer (Milton Roy-Spectronic 2ID-America).
The percent viability was calculated as follows: 
Ames test
Ames test is Salmonella /microsome mutagenicity assay designed to analysis of mutagenic and anti-mutagenic factors 14 . Salmonella TA100 used in this test have various mutations in histidine operon genes. Therefore, in the absence of histidine the bacteria are unable to grow and create colony. In presence of mutagen factors, reverse mutation is occurred so the bacteria are able to grow and form colony 15 .
Histidine dependent strain of Salmonella typhimurium TA100 used for Ames test.
S. typhimurium TA100 developed by Dr. Ames of the University of California, Berkeley, USA, was cultured in a nutrient broth (Sigma, America). The bacterial suspension was prepared 1-2 x 10 9 cells/ml fresh culture.
In order to preparation of the rat microsomal liver enzyme (S9), mature male rats (about 200 g body weights) were deprived of food for 48h to achieve high level hepatic enzymes. Then the rats were killed and the livers were removed. After washing the livers in PBS solution, the livers were cut in to small pieces and homogenized by 1M KCl solution. Finally this solution was centrifuged for 10 min at 8700 rpm. The supernatant was isolated and stored at -80° C.
Test groups: 100μl bacteria suspension plus 100μl histidine-biotin solution (24mg biotin plus 31 mg histidine were added to 250 ml distilled water) and then 100 μl Sodium Azide solution (10ml distilled water plus 0.015 g sodium Azide) was used to the test tube contain Top Agar (0.6 g Agar plus 0.5 g NaCl plus 100ml distilled water) and finally the test tubes were incubated with 1-7 mg/ml concentrations of HBV.
Positive control: 100μl bacteria suspension plus 100μl histidine-biotin solution and then 100 μl sodium Azide solution were combined to a tube contain Top Agar.
Negative control: 100μl bacteria suspension plus 100μl histidine-biotin solution and then 100 μl distilled water were combined to a test tube contain Top Agar.
Finally, the content of these tubes after 3 second shaking were distributed on the surface of minimum medium of glucose agar (%40 glucose). The plates were incubated at 37 C for 48 hours. All of these Anti-mutagenic assays were performed in the absence and presence of S9, and for each test three repeats were considered. 
MIC assay
Minimum Inhibitory Concentration assay for serial dilution concentrations of HBV was performed. Investigation of test tubes indicated that HBV can cause death in salmonella TA100 with dosages more than 8mg/ml. the tubes with 1mg/ml to 7mg/ml concentrations had cloudy view so the bacteria were able to grow. Hence the MIC of HBV on salmonella TA100 was determined 8mg/ml concentration.
Ames assay
In order to investigate the Anti-mutagenic and also anti-cancerous activities of HBV, Ames test was performed with 1-7 mg/ml concentrations of HBV (less than MIC) in the presence and absence of S9 fraction. After 48h reversed colonies were counted (figure2). The Plates with different concentrations of HBV have shown reduced revertants colonies in a dose dependent manner. Comparison of the test and positive control groups has shown significant differences (p<0.001) (figure3.A). Also Ames assay was performed in the presence of S9, and result indicated that anti-mutagenic activity was improved with S9 ( figure 3.B ). The inhibition percentages of HBV in the presence and absence of S9 were obtained 62.76 and 56.17 (figure4).
Discussion:
Breast cancer is the most prevalent cancer among women of developed countries, and its incidence has been expanding worldwide 16 . The cytotoxic chemotherapy is used to cure the early and late stages of most cancers in the recent decade 17 . In the 1970s, anticancer characteristic of cisplatin findings created revolution in the clinical chemotropic agents applications 18 . In this study our objectives were examination of the cytotoxic and anti-mutagenic effects of HBV and Cisplatin, on the mouse mammary carcinoma 4T1 cell. In the present study, we report the cytotoxic activity of cisplatin on 4T1 cell line. The IC 50 value determined for cisplatin was 25μg/ml after 24hr. The Cisplatin, cis-diamino-dichloro-platinum (II) (CDDP), a complex containing a central atom of platinum to which they have bond two ammonium ions and two chlorine ions in cis position with respect to the horizontal plane of the molecule 19 .
Positive charged metals are able to bind to negative charged biomolecule. Protein and nucleic acid are excellent targets for binding to metal ions 20 The results of various studies on the biological activity of HBV suggest that it is highly effective in several diseases such as arthritis, MS, and back pain 11 . In our experiments the concentration of HBV that inhibited growth by 50% (IC 50 ) after 24hr incubation 4T1 cell line was 6μg/ml. This data is different from the lethal dosage in other cell lines, for instances 1.43g/ml for mammary carcinoma MCa 23 , 2μg/ml for human leukemic U937 cell line 12 , 8μg/ml for A2780cp 21 , 2µg/ml for human melanoma A2058 cell lines 24 He presumed that HBV inhibits DNA repair and this may be the mechanism by which it increases bleomycin lethality and inhibits recovery from bleomycin-induced damage 23 . On the other hand, Gajski (2008) demonstrated that HBV induces singleand double-strand DNA breaks in human lymphocytes 29 . According to these findings and since cisplatin targets the DNA molecule it is probable that HBV is able to promote the cytotoxic effect of cisplatin via this mechanism. Our data in this study are in direction with Alizadeh et al. study on investigation of the synergistic effect of BV and cisplatin on human ovarian cancer cell line A2780cp in which HBV potentiated the cytotoxic effect of cisplatin 21 .
Mutation, a natural process that changes a DNA sequence, is one of the most important causes of cancer. Also changes in the structure of chromosomes have critical role to create the most of malignancies 31 . In this study HBV inhibited the reverted mutation in dose dependent manner. According to Ames theory the number of revertants colony in positive control plate (with carcinogen substrate) should be 2 times more than test plates. Also mutagen prevention percentage ranges have 3 classes interpretation include inhibitory percent more than 40% which show high prevention potential, between 25-40% which show medium potential and less than 25% which show negative prevention 31 . Hence, in this study, our results showed that the number of revertants colony in the test plate with 7 mg/ml concentration of HBV (with S9 and without S9) is equal to less than half of the number of colony in Positive control plate. On the other hand the inhibitory percent for 5mg/ml, 6 mg/ml and 7 mg/ml concentrations of HBV Respectively is 43.05%, 45.26%, and 56.17% in absence of S9, so these HBV concentrations showed high prevention potential.
Furthermore, the S9 fraction potentiated HBV inhibitory effect. The S9 fraction is prepared from the liver of rats and it contains hepatic enzyme which effectively bioactive promutagens to mutagens. This metabolic activation of mutagens is considered vital step for carcinogenesis, because most of carcinogen must enzymatically transformed to electrophilic specious. This activated mutagen is able to covalently bind to DNA molecule leading to mutation 32, 33 . Other studies were performed to investigate antimutagenic some natural products. In 2011 Ghazali et al. confirmed that extract of M. speciosa indicates anti-mutagenic activity 34 . Also Issazadeh and his coworkers (2012) concluded that olive leaf shows anti-mutagenic and anti-carcinogenic effects 30 . Also our data demonstrated that in the presence of S9 fraction, the mutagen prevention percent of HBV was promoted. Since S9 fraction activate sodium azide mutagen so it is likely that HBV prevents the mutagenic effects of sodium azide. Finally, our result in agreement with previous studies and its interpretation confirmed that HBV has anti-mutagenic and anti-cancerous effect in dependent dose manner.
Conclusion: According to our results in this study, we assessed that HBV as a natural product has cytotoxic effect on mouse mammary carcinoma 4T1 cell line.
Cisplatin as a chemotropic drug to cure several types of cancer has cytotoxic effect on 4T1 cell line, but in combination with HBV, its cytotoxic effect is potentiated and it can be more effective in non-lethal dosages. Furthermore, anti-mutagenic and anticancerous activities of HBV were seen in the presence of S9 metabolic activation system in the all concentrations of HBV. It will be an excellent perspective to innovate approaches to prevent and treat the some features of cancer. 
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